PMID- 26772533 OWN - NLM STAT- MEDLINE DCOM- 20160601 LR - 20220129 IS - 1365-229X (Electronic) IS - 0009-9260 (Print) IS - 0009-9260 (Linking) VI - 71 IP - 3 DP - 2016 Mar TI - Acute myocardial infarction: susceptibility-weighted cardiac MRI for the detection of reperfusion haemorrhage at 1.5 T. PG - e150-6 LID - S0009-9260(15)00493-6 [pii] LID - 10.1016/j.crad.2015.12.008 [doi] AB - AIM: To assess whether susceptibility-weighted imaging (SWI) provides better image contrast for the detection of haemorrhagic ischaemia-reperfusion injury in the heart. MATERIALS AND METHODS: Thirty patients (all men; mean age 53 years) underwent cardiac magnetic resonance imaging (MRI) within 7 days of primary percutaneous intervention for acute ST elevation myocardial infarction (STEMI). Multiple gradient-echo T2* sequences with magnitude and phase reconstructions were acquired. A high-pass filtered phase map was used to create a mask for the SWI reconstructions. The difference in image contrast was assessed in those patients with microvascular obstruction. A mixed effects regression model was used to test the effect of echo time and reconstruction method on phase and contrast-to-noise ratio (CNR). Medians and interquartile ranges (IQR) are reported. RESULTS: T2* in haemorrhagic infarcts was shorter than in non-haemorrhagic infarcts (33.5 ms [24.9-43] versus 49.9 ms [44.6-67.6]; p=0.0007). The effect of echo time on phase was significant (p<0.0001), as was the effect of haemorrhage on phase (p=0.0016). SWI reconstruction had a significant effect on the CNR at all echo times (echoes 1-5, p<0.0001; echo 6, p=0.01; echo 7, p=0.02). The median echo number at which haemorrhage was first visible was less for SWI compared to source images (echo 2 versus echo 5, p=0.0002). CONCLUSION: Cardiac SWI improves the contrast between myocardial haemorrhage and the surrounding tissue following STEMI and has potential as a new tool for identifying patients with ischaemia-reperfusion injury. CI - Copyright (c) 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. FAU - Durighel, G AU - Durighel G AD - Robert Steiner MRI Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. FAU - Tokarczuk, P F AU - Tokarczuk PF AD - Robert Steiner MRI Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. FAU - Karsa, A AU - Karsa A AD - Department of Physics, Budapest University of Technology and Economics, Budapest, Hungary. FAU - Gordon, F AU - Gordon F AD - Statistical Advisory Service, School of Public Health, Imperial College, London W12 1PG, UK. FAU - Cook, S A AU - Cook SA AD - Robert Steiner MRI Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK; Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK; Hammersmith Hospital, Du Cane Road, London W12 0HS, UK; Department of Cardiology, National Heart Centre Singapore, 17 Third Hospital Ave, Singapore 168752, Singapore; Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore. FAU - O'Regan, D P AU - O'Regan DP AD - Robert Steiner MRI Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. Electronic address: declan.oregan@imperial.ac.uk. LA - eng GR - MC_U120085815/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160106 PL - England TA - Clin Radiol JT - Clinical radiology JID - 1306016 RN - 0 (Contrast Media) RN - K2I13DR72L (Gadolinium DTPA) RN - XM0M87F357 (Ferrosoferric Oxide) SB - IM MH - Cardiac-Gated Imaging Techniques/*methods MH - Contrast Media MH - Ferrosoferric Oxide MH - Gadolinium DTPA MH - Hemorrhage/*diagnosis/*etiology MH - Humans MH - Image Interpretation, Computer-Assisted MH - Magnetic Resonance Imaging/*methods MH - Male MH - Middle Aged MH - Myocardial Infarction/*therapy MH - Myocardial Reperfusion/*adverse effects MH - Percutaneous Coronary Intervention MH - Phantoms, Imaging MH - Prospective Studies PMC - PMC5724752 MID - EMS75105 EDAT- 2016/01/17 06:00 MHDA- 2016/06/02 06:00 PMCR- 2017/12/11 CRDT- 2016/01/17 06:00 PHST- 2015/09/01 00:00 [received] PHST- 2015/11/19 00:00 [revised] PHST- 2015/12/14 00:00 [accepted] PHST- 2016/01/17 06:00 [entrez] PHST- 2016/01/17 06:00 [pubmed] PHST- 2016/06/02 06:00 [medline] PHST- 2017/12/11 00:00 [pmc-release] AID - S0009-9260(15)00493-6 [pii] AID - 10.1016/j.crad.2015.12.008 [doi] PST - ppublish SO - Clin Radiol. 2016 Mar;71(3):e150-6. doi: 10.1016/j.crad.2015.12.008. Epub 2016 Jan 6.